• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

    3/13/24 9:00:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email

    VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama.

    The transaction is structured as an asset purchase and parties will seek to close the transaction in the second quarter, subject to certain regulatory and other approvals.

    Nick Westfall, Chairman and CEO of VITAS Healthcare, stated, "Covenant Care has a 44-year history of providing high-quality, patient-centered care across communities in Florida and Alabama. Being a similar long-standing, mission-focused provider, VITAS is looking forward to building upon their legacy by following our key values of putting patients, families, and our team members first. We are excited to welcome the Covenant Care team members who decide to join our VITAS family as we collectively move forward with making a difference in all the communities we have the privilege of serving. I would also like to thank the Covenant Care executive team and Board of Directors whose vision for how this transaction will help to fulfill both organizations' commitment to our missions led us to this successful announcement today."

    Jeff Mislevy, President and CEO of Covenant Care, stated, "Today is a monumental day for Covenant Care because it allows the organization to broaden and deepen its focus on improving healthcare for the communities we serve by supporting new solutions and filling gaps in the care delivery system, while at the same time, keep our promise to the communities by continuing to deliver the world-class hospice and palliative care they deserve with the experts at VITAS Healthcare. As a result of the growth, expansion, and success over the past several years, it became clear that the organization was well positioned to join forces with a nationally renowned strategic partner. During this thorough search for the right provider, it was evident from the beginning that both our organizations shared an aligned culture, mission, and passion which led to the Board of Directors unanimously selecting VITAS Healthcare for this transaction."

    Dr. Rodney Guttmann, Chairman of the Covenant Care Board of Directors, stated "The Board of Directors is excited for today's announcement as it allows us to continue our mission of providing support for patient care and family grief through existing programs such as MyWish and Nonie's Place. Additionally, this allows us to expand our reach and impact by supporting solutions across the health care continuum with special focus on behavioral health, pediatrics, and veteran care."

    Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.

    Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240313721058/en/

    Get the next $CHE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/13/24 5:01:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/23 11:12:43 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/22 3:33:36 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    See more
    • VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

      VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

      3/13/24 9:00:00 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

      Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

      12/18/23 1:20:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Retirement of David P. Williams

      Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin

      11/3/23 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

      5/14/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS i

      5/6/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Walsh George J Iii was granted 277 units of Capital Stock, increasing direct ownership by 9% to 3,323 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:42:26 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mount John Meredith Jr. was granted 277 units of Capital Stock, increasing direct ownership by 42% to 930 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:33:04 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mccarthy Eileen P was granted 277 units of Capital Stock, increasing direct ownership by 48% to 855 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:28:19 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously

      3/4/22 8:31:07 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously

      7/29/21 10:52:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Oppenheimer reiterated coverage on Chemed with a new price target

      Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously

      3/3/21 8:11:56 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      12/30/24 11:10:35 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    SEC Filings

    See more
    • Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CHEMED CORP (0000019584) (Filer)

      5/20/25 2:00:14 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 filed by Chemed Corp

      S-8 - CHEMED CORP (0000019584) (Filer)

      5/20/25 10:21:08 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Chemed Corp

      10-Q - CHEMED CORP (0000019584) (Filer)

      4/28/25 9:06:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Financials

    Live finance-specific insights

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

      Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

      4/1/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care